NCT04421807

Brief Summary

The aim of the study is to investigate the effects of scapulathoracic stabilization exercises additionally applied to complex decongestive therapy after mastectomy on posture, balance and quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2020

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

May 29, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

June 9, 2020

Status Verified

June 1, 2020

Enrollment Period

8 months

First QC Date

May 29, 2020

Last Update Submit

June 4, 2020

Conditions

Keywords

Lymphedemadecongestive therapyexerciseposturebalance

Outcome Measures

Primary Outcomes (3)

  • Thoracic khyphosis

    Thoracic Kyphosis will be evaluated with digital inclinometer device (Baseline® Digital İnclinometer).

    change from baseline , at 4 weeks and at 8 weeks

  • Posture angle

    Posture angle will be evaluated with the PostureScreen Mobile (HuaweiTechnologies Co. Ltd, FIG-LX1, Android) application installed on a smartphone

    change from baseline , at 4 weeks and at 8 weeks

  • General posture status

    General posture status will be evaluated with the New York Posture Scale, postural changes that can occur in 13 different parts of the body are scored by observing the individual posteriorly and laterally. Each parameter is given 5 if smooth, 3 if moderately impaired, 1 if severely impaired. At the end of the scoring minimum 13, maximum 65 points can be obtained.

    change from baseline , at 4 weeks and at 8 weeks

Secondary Outcomes (8)

  • Balance

    change from baseline , at 4 weeks and at 8 weeks

  • Quality of life outcomes

    change from baseline , at 4 weeks and at 8 weeks

  • The severity of the lymphoedema

    change from baseline , at 4 weeks and at 8 weeks

  • Lymphedema symptoms

    change from baseline , at 4 weeks and at 8 weeks

  • Range of motion of shoulder

    change from baseline , at 4 weeks and at 8 weeks

  • +3 more secondary outcomes

Study Arms (2)

Exercise+Complex decongestive therapy (CDT) group

EXPERIMENTAL

The patients diagnosed with lymphedema with 18-65years of age followed by routine controls and who were volunteered will be included in the study

Other: Scapulatoracic stabilization exercisesOther: Complex decongestive therapy (CDT)

Only Complex decongestive therapy (CDT) group

ACTIVE COMPARATOR

The patients diagnosed with lymphedema with 18-65years of age followed by routine controls and who were volunteered will be included in the study

Other: Complex decongestive therapy (CDT)

Interventions

Scapulatoracic stabilization exercises consisted of 3 phases; the warming phase which consists of mobility and stretching; exercise phase consisting of static, dynamic and functional phase; the cooling phase consisting of mobility and stretching. Scapulatoracic stabilization exercises additionally applied to CDT were performed 3 days a week for 8 weeks. These exercises were specially planned for the patients and applied gradually

Exercise+Complex decongestive therapy (CDT) group

In the treatment phase of CDT, manual lymph drainage, skin care, compression bandage, draining exercise were applied 5 days a week for 3 weeks. Compression socks, self-drainage, skin care and unloading exercises were applied for 5 weeks in the protection phase of CDT. Thus, patients were followed up with the CDT program for 8 weeks.

Exercise+Complex decongestive therapy (CDT) groupOnly Complex decongestive therapy (CDT) group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen with lymphedema after mastectomy
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to 65 years of age
  • Agree to participate in the study,
  • Undergoing unilateral mastectomy due to breast cancer treatment and additionally development of limb lymphedema,
  • Lymphedema stage 2 and 3,
  • Being a woman,
  • Having spent at least 6 months after the operation
  • With or without radiotherapy and / or chemotherapy.

You may not qualify if:

  • Irregular participation to the treatment program,
  • Severe heart failure and / or rhythm disturbance,
  • Uncontrolled hypertension,
  • Presence of metastasis,
  • Infection in the affected arm,
  • Any problems that may affect balance (rheumatological, vestibular, visual, neurological),
  • Muscular and skeletal system problems (limb shortness, ankle sprain ...), which may affect the balance and posture negatively.
  • Presence of spinal deformity,
  • Those who have had spinal surgery in the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Yildirim Beyazit University

Ankara, 06760, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

LymphedemaMotor Activity

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesBehavior

Study Officials

  • Seyda TOPRAK CELENAY

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seyda TOPRAK CELENAY

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 29, 2020

First Posted

June 9, 2020

Study Start

May 20, 2020

Primary Completion

January 1, 2021

Study Completion

June 1, 2021

Last Updated

June 9, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations